Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:LSTNASDAQ:NITENYSEARCA:SAMMNASDAQ:VMOT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLSTLeuthold Select Industries ETF$37.13+1.1%$34.86$29.04▼$37.13$22.53MN/A5,279 shs965 shsNITENightstar Therapeutics$31.46+0.5%$25.41$9.59▼$29.55$1.06B2.84185,808 shs1,092 shsSAMMStrategas Macro Momentum ETF$27.67+0.9%$26.04$21.88▼$29.44$15.77M1.193,168 shs2,113 shsVMOTAlpha Architect Value Momentum Trend ETF$27.06+0.8%$25.94$23.03▼$27.77$22.46M0.481,645 shs370 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLSTLeuthold Select Industries ETF+1.12%+2.09%+5.27%+25.31%+3,712,999,900.00%NITENightstar Therapeutics+1.17%+2.66%+5.55%+24.24%+19.20%SAMMStrategas Macro Momentum ETF+0.95%+1.28%+5.41%+22.87%+9.37%VMOTAlpha Architect Value Momentum Trend ETF0.00%+2.90%+2.48%+14.77%+8.19%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLSTLeuthold Select Industries ETFN/AN/AN/AN/AN/AN/AN/AN/ANITENightstar TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ASAMMStrategas Macro Momentum ETFN/AN/AN/AN/AN/AN/AN/AN/AVMOTAlpha Architect Value Momentum Trend ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLSTLeuthold Select Industries ETF 2.75Moderate Buy$37.13N/ANITENightstar Therapeutics 0.00N/AN/AN/ASAMMStrategas Macro Momentum ETF 2.72Moderate Buy$27.67N/AVMOTAlpha Architect Value Momentum Trend ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLSTLeuthold Select Industries ETFN/AN/AN/AN/AN/AN/ANITENightstar TherapeuticsN/AN/AN/AN/A$5.89 per shareN/ASAMMStrategas Macro Momentum ETFN/AN/AN/AN/AN/AN/AVMOTAlpha Architect Value Momentum Trend ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLSTLeuthold Select Industries ETFN/AN/A17.27∞N/AN/AN/AN/AN/ANITENightstar Therapeutics-$36.86M-$1.26N/AN/AN/AN/A-30.89%-27.65%N/ASAMMStrategas Macro Momentum ETFN/AN/A18.49∞N/AN/AN/AN/AN/AVMOTAlpha Architect Value Momentum Trend ETFN/AN/A13.56∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLSTLeuthold Select Industries ETFN/AN/AN/AN/AN/ANITENightstar TherapeuticsN/AN/AN/AN/AN/ASAMMStrategas Macro Momentum ETF$0.190.69%N/AN/AN/AVMOTAlpha Architect Value Momentum Trend ETF$0.642.37%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLSTLeuthold Select Industries ETFN/AN/AN/ANITENightstar TherapeuticsN/A8.548.54SAMMStrategas Macro Momentum ETFN/AN/AN/AVMOTAlpha Architect Value Momentum Trend ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLSTLeuthold Select Industries ETFN/ANITENightstar Therapeutics32.83%SAMMStrategas Macro Momentum ETFN/AVMOTAlpha Architect Value Momentum Trend ETFN/AInsider OwnershipCompanyInsider OwnershipLSTLeuthold Select Industries ETFN/ANITENightstar TherapeuticsN/ASAMMStrategas Macro Momentum ETFN/AVMOTAlpha Architect Value Momentum Trend ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLSTLeuthold Select Industries ETFN/A606,875N/AN/ANITENightstar Therapeutics4733.54 millionN/ANot OptionableSAMMStrategas Macro Momentum ETFN/A570,000N/AN/AVMOTAlpha Architect Value Momentum Trend ETFN/A830,000N/AN/ALST, VMOT, NITE, and SAMM HeadlinesRecent News About These CompaniesTime for Global Equities ETFs?September 20, 2024 | zacks.comTop HeadlinesView All HeadlinesA Large Oil Supply Draw Could Mean Upside in These 3 Energy NamesBy Gabriel Osorio-Mazilli | June 6, 2025View A Large Oil Supply Draw Could Mean Upside in These 3 Energy NamesUnitedHealth Stock Dips: Is This a Value Buy Opportunity?By Jeffrey Neal Johnson | June 13, 2025View UnitedHealth Stock Dips: Is This a Value Buy Opportunity?Top Steel Picks for the Coming Infrastructure BoomBy Chris Markoch | June 25, 2025View Top Steel Picks for the Coming Infrastructure BoomRocket Lab: Latest Catalysts Bolster the Bull CaseBy Ryan Hasson | July 3, 2025View Rocket Lab: Latest Catalysts Bolster the Bull CaseUPS Is Outpacing the Market: A Green Light for Investors?By Jeffrey Neal Johnson | June 27, 2025View UPS Is Outpacing the Market: A Green Light for Investors?LST, VMOT, NITE, and SAMM Company DescriptionsLeuthold Select Industries ETF NYSEARCA:LST$37.13 +0.41 (+1.12%) As of 07/3/2025 05:00 PM EasternThe Leuthold Select Industries ETF (LST) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking capital appreciation by broadly investing in US equity securities. The selection process utilizes a quantitative approach that focuses on shifts in industry groups LST was launched on Jan 21, 2025 and is issued by Leuthold.Nightstar Therapeutics NASDAQ:NITENightstar Therapeutics plc, a clinical-stage gene therapy company, focuses on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases in the United Kingdom. The company's lead product candidate is NSR-REP1, a candidate that is in phase 3 clinical development for the treatment of patients with choroideremia. It is also developing NSR-RPGR, a candidate that is in Phase 1/2 clinical trials for the treatment of patients with X-linked retinitis pigmentosa, an inherited X-linked recessive retinal disease; and NSR-BEST1, a candidate that is in preclinical development stage for the treatment of best vitelliform macular dystrophy. In addition, the company is developing NSR-ABCA4, a candidate that is in preclinical development stage for the treatment of Stargardt disease. The company was founded in 2013 and is headquartered in London, the United Kingdom.Strategas Macro Momentum ETF NYSEARCA:SAMM$27.67 +0.26 (+0.95%) As of 07/3/2025 05:00 PM EasternThe Strategas Macro Momentum ETF (SAMM) is an exchange-traded fund that mostly invests in total market equity. The fund primarily invests in 20-50 US equities selected through a tactical, macro momentum approach that looks for strong technical, momentum, and relative strength characteristics. The actively managed fund aims for a more defensive posture when the indicators turn negative. SAMM was launched on Apr 3, 2024 and is issued by Strategas.Alpha Architect Value Momentum Trend ETF NASDAQ:VMOT$27.06 +0.21 (+0.79%) As of 06/27/2025The Alpha Architect Value Momentum Trend ETF (VMOT) is an exchange-traded fund that mostly invests in total market equity. The fund is an active, equal-risk-weighted portfolio of value- and momentum-oriented ETFs. The fund can fully hedge its equity exposure in down-trending markets. VMOT was launched on May 3, 2017 and is issued by Alpha Architect. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Nike's Stock Just Got an Upgrade: Is a Real Comeback Brewing? Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
